This Web site aims to provide news about area events and updates on research and advancements in the south centra Indiana breast cancer medical community. Check out the mission statement or read about the origins of BC:FYI.
Step Ahead meets Dec. 10
Step Ahead, the support group for survivors, meets Dec. 10 at the Scholars Bakehouse East in Bloomington. Join us at 6 p.m. Look for the the pink tablecloths. Learn more about the group at the Events page.
Olcott Center offers support group
The Olcott Center for Cancer Education's breast cancer support group meets at 7 p.m. Dec. 5. The center is behind the hospital in the Medical Arts Building 619 W. First St. Call 812-353-5669 for more info or check the Olcott website.
Follow up clinic available
A new Breast Cancer Care Follow-up Clinic will be open for walk-ins the second Tuesday of every month at the IU Health Rehabilitation and Sports Medicine Center West, 2499 W. Cota Dr. Certified lymphedema therapists will provide screenings of limb volume and upper extremity range of motion and strength. For more info, call 812-353-9378 or email the clinic.
10 years of tamoxifen best?
Two studies have found that taking tamoxifen for 10 years instead of the long-recommended five years may provide extended risk for recurrence, two studies have found. You'll want to read about what this means for the side effects of blood clots and endometrial cancer, which often were cited as reasons for stopping tamoxifen after five years. This report from ASCO also sums up the findings.
Court rules genes cannot be patented
The Supreme Court ruled June 13 that DNA occurs in nature and companies cannot patent genes found in humans. This is a setback for companies such as Myriad, which developed a genetic test for the BRCA breast cancer genes, but others say the ruling will open up more avenues to testing as well as more paths for researchers to conduct their own explorations into genetic causes for disease. Shortly after the ruling, several universities and labs said they would begin offering testing for BRCA 1 and 2 immediately.Read a recap from the New York Times, and check out this article from Breast Cancer Action.org.
Coming soon to your inbox
Interested in getting your Breast Cancer: FYI news in your email inbox? Subscribe to a periodic newsletter with info and links to news affecting the breast cancer community. And don't forget to follow BC:FYI on Twitter, @breastcancerfyi, and Facebook, Breast Cancer: FYI.
Join BC:FYI on Facebook, Twitter
At your service:
- E-mail me at Webmaster@BreastCancerFYI.org if you need additional information about a topic, or would like to see articles posted about a topic not covered. Also, please report dead links, changes in times and locations for local meetings, or other corrections.
- Why Breast Cancer:FYI? My Story
- Breast Cancer:FYI Mission Statement
- Honors and Awards for Breast Cancer:FYI
- Who is the Web master?